Literature DB >> 7901684

Tretinoin toxicity in children with acute promyelocytic leukaemia.

H H Mahmoud1, C A Hurwitz, W M Roberts, V M Santana, R C Ribeiro, R A Krance.   

Abstract

Tretinoin is effective in acute promyelocytic leukaemia in adults. Data about its efficacy and safety in children are limited. We have treated 9 children with tretinoin at 45 mg/m2 per day. Pseudotumour cerebri or hyperleucocytosis occurred in 5 patients. Retinoic acid syndrome was seen in 3 cases. 1 of 2 children who developed hyperleucocytosis, pseudotumour cerebri, and retinoic acid syndrome died despite steroids and mechanical ventilation. Complete remissions with tretinoin alone were achieved in 15 patients. All 8 surviving children received consolidation chemotherapy. Our experience with tretinoin therapy suggests that toxicity is frequent in children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901684     DOI: 10.1016/0140-6736(93)92755-i

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia.

Authors:  Yu-Chen Yeh; Huei-Fen Tang; I-Mo Fang
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

2.  Pseudotumor cerebri in a child in early phase of induction therapy for APL with ATRA.

Authors:  Rahul Naithani; Rajat Kumar; Pravas Mishra
Journal:  Indian J Pediatr       Date:  2009-04       Impact factor: 1.967

Review 3.  Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI).

Authors:  M Smith; P T Ho
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

4.  Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia.

Authors:  J Labrador; N Puig; A Ortín; N C Gutierrez; M González-Díaz
Journal:  Int J Hematol       Date:  2012-07-06       Impact factor: 2.490

5.  ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia.

Authors:  Ramzi Jeddi; Hèlà Ghédira; Yosr Ben Abdennebi; Karima Kacem; Ramzi Ben Amor; Lamia Aissaoui; Walid Bouterâa; Raihane Ben Lakhal; Hèla Ben Abid; Samia Menif; Zaher Belhadjali; Balkis Meddeb
Journal:  Med Oncol       Date:  2010-08-10       Impact factor: 3.064

Review 6.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

Review 7.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

8.  All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.

Authors:  Dylan Holmes; Prakash Vishnu; Russell K Dorer; David M Aboulafia
Journal:  Case Rep Oncol Med       Date:  2012-06-03

9.  Newly diagnosed acute promyelocytic leukemia.

Authors:  Giuseppe Avvisati
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-20       Impact factor: 2.576

10.  Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: a case report.

Authors:  Fahid T Rasul; Ahmed K Toma; Akbar A Khan; Gordon T Plant; Laurence D Watkins
Journal:  J Med Case Rep       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.